| Authors: |
Heinrich K; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany; Comprehensive Cancer Center, University Hospital (LMU), Munich, Germany. Electronic address: kathrin.heinrich@med.uni-muenchen.de., Stintzing S; Department of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany; German Cancer Consortium (DKTK), German Cancer Research Centre (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT) Berlin, German Cancer Research Centre (DKFZ), Heidelberg, Germany., Weikersthal LFV; Gesundheitszentrum St. Marien, Amberg, Germany., Decker T; Onkologie Ravensburg, Ravensburg, Germany., Kiani A; Department of Medicine IV, Klinikum Bayreuth GmbH, Bayreuth, and Comprehensive Cancer Center Erlangen EMN, Erlangen, Germany., Kaiser F; Oncological Practice, Landshut, Germany., Al-Batran SE; Institute of Clinical Cancer Research at Krankenhaus Nordwest University Cancer Center, Frankfurt, Germany., Heintges T; Department of Medicine II, Städtische Kliniken Neuss, Neuss, Germany., Lerchenmüller C; Oncological Practice, Münster, Germany., Kahl C; Department of Haematology and Oncology, Städtisches Klinikum Magdeburg, Magdeburg, Germany., Seipelt G; Oncological Practice, Bad Soden, Germany., Kullmann F; Department of Medicine I, Klinikum Weiden, Weiden, Germany., Moehler M; Department of Medicine II, University Hospital, Johannes Gutenberg University Mainz, Mainz, Germany., Scheithauer W; Department of Internal Medicine I and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Jung A; Institute of Pathology, University of Munich, Munich, Germany., Holch JW; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany; Comprehensive Cancer Center, University Hospital (LMU), Munich, Germany., Held S; AIO-Studien-gGmbH, Germany., Modest DP; Department of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany; German Cancer Consortium (DKTK), German Cancer Research Centre (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT) Berlin, German Cancer Research Centre (DKFZ), Heidelberg, Germany., Heinemann V; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany; Comprehensive Cancer Center, University Hospital (LMU), Munich, Germany. |
